|
ATE538794T1
(de)
|
1999-01-13 |
2012-01-15 |
Bayer Healthcare Llc |
Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
|
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
US7351834B1
(en)
|
1999-01-13 |
2008-04-01 |
Bayer Pharmaceuticals Corporation |
ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
WO2003068229A1
(en)
|
2002-02-11 |
2003-08-21 |
Bayer Pharmaceuticals Corporation |
Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
|
|
MXPA04007832A
(es)
|
2002-02-11 |
2005-09-08 |
Bayer Pharmaceuticals Corp |
Aril-ureas con actividad inhibitoria de angiogenesis.
|
|
JP4628678B2
(ja)
*
|
2002-03-29 |
2011-02-09 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
置換ベンズアゾールおよびＲａｆキナーゼ阻害剤としてのそれらの使用
|
|
UY28213A1
(es)
|
2003-02-28 |
2004-09-30 |
Bayer Pharmaceuticals Corp |
Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
|
|
CA2526285A1
(en)
|
2003-05-15 |
2004-12-23 |
Arqule, Inc. |
Inhibitors of p38 and methods of using the same
|
|
EP1636585B2
(en)
|
2003-05-20 |
2012-06-13 |
Bayer HealthCare LLC |
Diaryl ureas with kinase inhibiting activity
|
|
HRP20060073B1
(hr)
|
2003-07-23 |
2014-03-14 |
Bayer Healthcare Llc |
Fluoro supstituirana omega-karboksiaril difenil urea za lijeäśenje i prevenciju bolesti i stanja
|
|
CA2542653A1
(en)
*
|
2003-10-16 |
2005-04-28 |
Chiron Corporation |
Substituted benzazoles and use thereof as inhibitors of raf kinase
|
|
US7829560B2
(en)
*
|
2004-07-08 |
2010-11-09 |
Arqule, Inc. |
1,4-disubstituted naphthalenes as inhibitors of P38 MAP kinase
|
|
US8178672B2
(en)
*
|
2004-10-19 |
2012-05-15 |
Arqule, Inc. |
Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 MAP kinase
|
|
US7429608B2
(en)
*
|
2005-01-20 |
2008-09-30 |
Amgen Inc. |
Benzo[d]imidazol analogs as vanilloid receptor ligands and their use in treatments
|
|
TWI370820B
(en)
*
|
2005-04-27 |
2012-08-21 |
Takeda Pharmaceutical |
Fused heterocyclic compounds
|
|
PE20070427A1
(es)
*
|
2005-08-30 |
2007-04-21 |
Novartis Ag |
Compuestos derivados de benzimidazoles sustituidos como inhibidores de tirosina quinasas
|
|
WO2007047397A2
(en)
*
|
2005-10-13 |
2007-04-26 |
Smithkline Beecham Corporation |
Phenol ethers as modulators of the opioid receptors
|
|
EP2295432A1
(en)
|
2006-02-10 |
2011-03-16 |
TransTech Pharma Inc. |
Process for the preparation of aminobenzimidazole derivatives
|
|
PE20080359A1
(es)
|
2006-04-19 |
2008-06-06 |
Novartis Ag |
Compuestos de benzoxazol y benzotiazol 6-0-sustituidos y metodos de inhibicion de la senalizacion de csf-1r
|
|
DK2046292T3
(da)
|
2006-07-21 |
2010-06-07 |
Novartis Ag |
Formuleringer for benzimidazolylpyridylethere
|
|
PE20080766A1
(es)
*
|
2006-08-30 |
2008-06-15 |
Novartis Ag |
Sales de benzimidazolil piridil eteres y formulaciones que las contienen
|
|
AU2008239179B2
(en)
*
|
2007-04-05 |
2011-02-24 |
Daiichi Sankyo Company, Limited |
Fused bicyclic heteroaryl derivatives
|
|
AR066845A1
(es)
|
2007-06-05 |
2009-09-16 |
Takeda Pharmaceutical |
Derivados de triazolopiridina e imidazopiridina una composicion farmaceutica que los comprende y su uso en la preparacion de un medicamento para el tratamiento del cancer
|
|
EP2181987B9
(en)
|
2007-08-23 |
2014-09-03 |
Takeda Pharmaceutical Company Limited |
2-Carbonylaminobenzothiazoles and their use for the prophylaxis and treatment of cancer
|
|
EP2184285B1
(en)
*
|
2007-08-29 |
2015-11-04 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound and use thereof
|
|
BRPI0816881A2
(pt)
*
|
2007-09-21 |
2015-03-17 |
Array Biopharma Inc |
Composto, composição farmacêutica, uso de um composto, e, métodos para tratar doenças ou distúrbios e para preparar um composto.
|
|
WO2009050228A2
(en)
*
|
2007-10-18 |
2009-04-23 |
Novartis Ag |
Csf-1r inhibitors for treatment of cancer and bone diseases
|
|
WO2010064611A1
(ja)
*
|
2008-12-01 |
2010-06-10 |
武田薬品工業株式会社 |
複素環化合物およびその用途
|
|
JO3101B1
(ar)
|
2008-12-02 |
2017-09-20 |
Takeda Pharmaceuticals Co |
مشتقات بنزوثيازول كعوامل مضادة للسرطان
|
|
KR20110100241A
(ko)
*
|
2008-12-05 |
2011-09-09 |
아르퀼 인코포레이티드 |
Ｒａｆ 억제제 및 이들의 용도
|
|
CN102341386A
(zh)
|
2009-03-05 |
2012-02-01 |
第一三共株式会社 |
吡啶衍生物
|
|
AU2011265254B2
(en)
|
2010-06-11 |
2016-05-19 |
Smith & Nephew, Inc. |
Patient-matched instruments
|
|
EP2593434A1
(en)
|
2010-07-16 |
2013-05-22 |
Purdue Pharma LP |
Pyridine compounds as sodium channel blockers
|
|
AU2011303597A1
(en)
|
2010-09-17 |
2013-04-11 |
Purdue Pharma L.P. |
Pyridine compounds and the uses thereof
|
|
CN102276482A
(zh)
*
|
2011-04-11 |
2011-12-14 |
常州大学 |
2-甲氧基-5-溴苯胺的制备方法
|
|
US9408885B2
(en)
|
2011-12-01 |
2016-08-09 |
Vib Vzw |
Combinations of therapeutic agents for treating melanoma
|
|
AU2013203824A1
(en)
|
2012-03-16 |
2013-10-03 |
Purdue Pharma L.P. |
Substituted pyridines and pryimidines as sodium channel blockers
|
|
US9714252B2
(en)
|
2012-12-20 |
2017-07-25 |
Purdue Pharma L.P. |
Cyclic sulfonamides as sodium channel blockers
|
|
US9242969B2
(en)
|
2013-03-14 |
2016-01-26 |
Novartis Ag |
Biaryl amide compounds as kinase inhibitors
|
|
CN103435554A
(zh)
*
|
2013-09-06 |
2013-12-11 |
中国药科大学 |
2-苯氨基苯并咪唑类化合物及其用途
|
|
WO2015041534A1
(en)
|
2013-09-20 |
2015-03-26 |
Stichting Het Nederlands Kanker Instituut |
P90rsk in combination with raf/erk/mek
|
|
EP3046557A1
(en)
|
2013-09-20 |
2016-07-27 |
Stichting Het Nederlands Kanker Instituut |
Rock in combination with mapk-pathway
|
|
US10730866B2
(en)
|
2014-04-07 |
2020-08-04 |
Purdue Pharma L.P. |
Indole derivatives and use thereof
|
|
US20170027940A1
(en)
|
2014-04-10 |
2017-02-02 |
Stichting Het Nederlands Kanker Instituut |
Method for treating cancer
|
|
WO2015178770A1
(en)
|
2014-05-19 |
2015-11-26 |
Stichting Het Nederlands Kanker Instituut |
Compositions for cancer treatment
|
|
UY36294A
(es)
|
2014-09-12 |
2016-04-29 |
Novartis Ag |
Compuestos y composiciones como inhibidores de quinasa
|
|
WO2016100184A1
(en)
|
2014-12-16 |
2016-06-23 |
Forum Pharmaceuticals, Inc. |
Geminal substituted quinuclidine amide compounds as agonists of alpha-7 nicotinic acetylcholine receptors
|
|
CN105949178B
(zh)
*
|
2015-03-09 |
2020-05-26 |
西格莱(苏州)生物医药有限公司 |
一种苯并咪唑类化合物、其制备方法、中间体及应用
|
|
JP2018516973A
(ja)
|
2015-06-10 |
2018-06-28 |
フォーラム・ファーマシューティカルズ・インコーポレイテッドＦｏｒｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． |
α７−ニコチン性アセチルコリン受容体のアゴニストとしてのアミノベンゾイソオキサゾール化合物
|
|
EP3334740A4
(en)
|
2015-08-12 |
2019-02-06 |
Axovant Sciences GmbH |
GEMINAL SUBSTITUTED AMINOBENZISOXAZOLE COMPOUNDS AS AGONISTS OF ALPHA 7-NICOTINIC ACETYLCHOLINE RECEPTORS
|
|
KR101770310B1
(ko)
|
2015-08-24 |
2017-08-24 |
이화여자대학교 산학협력단 |
2-(페닐아미노)벤조[d]옥사졸-5-올 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 염증성 질환의 예방 또는 치료용 약학적 조성물
|
|
US11028055B2
(en)
*
|
2015-11-30 |
2021-06-08 |
Children's Medical Center Corporation |
Compounds for treating proliferative diseases
|
|
CA3037456A1
(en)
|
2016-09-19 |
2018-03-22 |
Novartis Ag |
Therapeutic combinations comprising a raf inhibitor and a erk inhibitor
|
|
CN106674264A
(zh)
*
|
2016-12-20 |
2017-05-17 |
苏州汉德创宏生化科技有限公司 |
(2,2,2‑三氟乙氧基)苯硼酸类化合物的合成方法
|
|
US11471538B2
(en)
|
2017-02-10 |
2022-10-18 |
INSERM (Institut National de la Santéet de la Recherche Medicale) |
Methods and pharmaceutical compositions for the treatment of cancers associated with activation of the MAPK pathway
|
|
WO2018168899A1
(ja)
|
2017-03-15 |
2018-09-20 |
大日本住友製薬株式会社 |
ベンズイミダゾール誘導体の製造方法
|
|
IL270224B1
(en)
|
2017-05-02 |
2024-04-01 |
Novartis Ag |
Combination therapy employing trametinib and a defined raf inhibitor
|
|
US11299488B2
(en)
*
|
2017-07-12 |
2022-04-12 |
Bristol-Myers Squibb Company |
Five membered-aminoheterocycle and 5,6-or 6,6-membered bicyclic aminoheterocyclic inhibitors of rock for the treatment of heart failure
|
|
US11339157B1
(en)
|
2017-10-24 |
2022-05-24 |
Bayer Aktiengesellschaft |
4H-pyrrolo[3,2-c]pyridin-4-one derivatives
|
|
EP3732285A1
(en)
|
2017-12-28 |
2020-11-04 |
Tract Pharmaceuticals, Inc. |
Stem cell culture systems for columnar epithelial stem cells, and uses related thereto
|
|
WO2019156438A1
(en)
*
|
2018-02-07 |
2019-08-15 |
Korea Research Institute Of Chemical Technology |
Hetero ring-fused phenyl compounds for inhibiting tnik and medical uses thereof
|
|
JP2022500385A
(ja)
|
2018-09-10 |
2022-01-04 |
ミラティ セラピューティクス， インコーポレイテッド |
組み合わせ療法
|
|
WO2020097398A1
(en)
|
2018-11-07 |
2020-05-14 |
Dana-Farber Cancer Institute, Inc. |
Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof
|
|
WO2020216774A1
(en)
|
2019-04-24 |
2020-10-29 |
Bayer Aktiengesellschaft |
4h-pyrrolo[3,2-c]pyridin-4-one derivatives
|
|
BR112021019998B1
(pt)
|
2019-04-24 |
2024-01-16 |
The Broad Institute, Inc. |
4h-pirrolo[3,2-c]piridin-4-ona, seus usos, composição farmacêutica, e kit de partes
|
|
WO2020216773A1
(en)
|
2019-04-24 |
2020-10-29 |
Bayer Aktiengesellschaft |
4h-pyrrolo[3,2-c]pyridin-4-one compounds
|
|
EP4563150A3
(en)
|
2019-05-13 |
2025-07-23 |
Novartis AG |
New crystalline forms of n-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2(trifluoromethyl) isonicotinamide as raf inhibitors for the treatment of cancer
|
|
CA3177214A1
(en)
|
2020-03-31 |
2021-10-07 |
Bayer Aktiengesellschaft |
3-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one derivatives as egfr inhibitors for the treatment of cancer
|
|
CA3181537A1
(en)
|
2020-05-06 |
2021-11-11 |
Ajax Therapeutics, Inc. |
6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
|
|
EP4263531A2
(en)
*
|
2020-12-16 |
2023-10-25 |
IFM Due, Inc. |
Compounds and compositions for treating conditions associated with sting activity
|
|
WO2022140527A1
(en)
|
2020-12-23 |
2022-06-30 |
Ajax Therapeutics, Inc. |
6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
|
|
WO2023009708A1
(en)
*
|
2021-07-29 |
2023-02-02 |
Ajax Therapeutics, Inc. |
Heteroaryloxy triazolo- and imidazo-azines as jak2 inhibitors
|
|
TW202325289A
(zh)
|
2021-11-09 |
2023-07-01 |
美商雅捷可斯治療公司 |
Ｊａｋ２抑制劑之形式及組合物
|
|
CA3234638A1
(en)
|
2021-11-09 |
2023-05-19 |
Ajax Therapeutics, Inc. |
6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
|